Antimicrobial and genotoxic activities of N-(2-hydroxyethyl)-1,2-benzisothiazol-3(2H)-thione carbamic esters

Farmaco

Volumn 54, Issue 10, 1999, Pages 643-647

  Zani, Franca ^a   Pregnolato, Massimo ^b   Zampollo, Fabrizio ^c  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c JOINT RESEARCH CENTRE   (Italy)

Author keywords

1,2 Benzisothiazole derivatives; Antimicrobial activity; Genotoxicity

Indexed keywords

1,2 BENZISOTHIAZOLE DERIVATIVE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CARBAMIC ACID ESTER;

AMES TEST; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CANDIDA; CANDIDA ALBICANS; CANDIDA GUILLIERMONDII; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DERMATOPHYTE; GENOTOXICITY; MINIMUM INHIBITORY CONCENTRATION; MOULD; MUTAGENIC ACTIVITY; NONHUMAN; SACCHAROMYCES CEREVISIAE; STAPHYLOCOCCUS ALBUS; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; YEAST;

ANTI-BACTERIAL AGENTS; CARBAMATES; DNA; DNA DAMAGE; MICROBIAL SENSITIVITY TESTS; MUTAGENICITY TESTS; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 0032720295     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00055-5     Document Type: Article

References (23)

1. De A. Ellis G.P., West G.B. Progress in Medicinal Chemistry. 18:1981;117-133 Elsevier/North-Holland Biomedical Press.
2. Davis M. Katritzky A.R., Boulton A.J. Advances in Heterocyclic Chemistry. 38:1985;114-116 Academic Press, New York.
3. Okachi R., Niino H., Kitaura K., Mineura K., Nakamizo Y., Murayama Y., Ono T., Nakamizo A. J. Med. Chem. 28:1985;1772-1779.
4. H. Kluschanzoff, R. Lehmann, H.T. Leinen (Henkel K.-G.a.A.), Ger. Offen. DE 4 217 881 [Chem. Abstr. 120 (1994) 71556t].
5. H. Eggensperger, P. Oltmanns, K.H. Scheler, K.H. Diehl (Sterling Winthrop, Inc.), U.S. US 5 276 047 [Chem. Abstr. 120 (1994) 144174d].
6. J.D. Payne (Zeneca Ltd), PCT Int. Appl. WO 94 16,564 [Chem Abstr. 121 (1994) 295086y].
7. P.W. Austin (Zeneca Ltd), PCT Int. Appl. WO 94 20 479 [Chem. Abstr. 121 (1994) 300882m].
8. H. Egawa (Shinto Paint Co Ltd), Jpn. Kokai Tokkyo Koho JP 06 305 917 [94 305 917] [Chem. Abstr. 122 (1995) 99324f].
9. H. Sugano, T. Nita, H. Yamamoto T. Kamagami, M. Odagiri (Junsei Chemical), Jpn. Kokai Tokkyo Koho JP 07 02 606 [95 02 606] [Chem. Abstr. 122 (1995) 180993y].
10. S. Hiraiwa, T. Nakano, K. Suzuki, H. Nakao (Toray Industries; Osaka Kasei Kk), Jpn. Kokai Tokkyo Koho JP 06 313 269 [94 313 269] [Chem. Abstr. 122 (1995) 242251n].
11. Carmellino M.L., Pagani G., Terreni M., Pregnolato M., Borgna P., Pastoni F., Zani F. Il Farmaco. 52:1997;359-366.
12. Borgna P., Carmellino M.L., Natangelo M., Pagani G., Pastoni F., Pregnolato M., Terreni M. Eur. J. Med. Chem. 31:1996;919-925.
13. Pagani G., Borgna P., Piersimoni C., Nista D., Terreni M., Pregnolato M. Arch. Pharm. Pharm. Med. Chem. 329:1996;421-425.
14. Rinkus S.J., Legator M.S. Cancer Res. 39:1979;3289-3318.
15. Schlatter J., Lutz W.K. Fd. Chem. Toxic. 28:1990;205-211.
16. Ashby A., Tennant R.W. Mutat. Res. 257:1991;229-306.
17. Wild D. Mutat. Res. 260:1991;309-310.
18. Park K., Liem A., Stewart B.C., Miller J.A. Carcinogenesis. 14:1993;441-450.
19. P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tonover, R.H. Yolken (Eds.), Manual of Clinical Microbiology, 6th ed., American Society of Microbiology, Washington, DC, 1995, section X.
20. Mazza P. Appl. Environ. Microbiol. 43:1982;177-184.
21. Maron D.M., Ames B.N. Mutat. Res. 113:1983;173-215.
22. Ashby J., Tennant R.W. Mutat. Res. 204:1988;17-115.
23. Rosenkranz H.S., Klopman G. Mutagenesis. 5:1990;333-361.